← FDA DRUG APPROVALS

FDA ANDA · ANDA090290

DONEPEZIL HYDROCHLORIDE

Sponsor: AIPING PHARM INC

APPLICATION
ANDA090290
TYPE
ANDA
ORIGINAL APPROVAL
2011-05-31
LATEST ACTION
2019-05-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DONEPEZIL HYDROCHLORIDEDiscontinued
DONEPEZIL HYDROCHLORIDE 10MG · TABLET · ORAL
DONEPEZIL HYDROCHLORIDEDiscontinued
DONEPEZIL HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2019-05-21Labeling · Supplement 9 · standardAP
2014-11-03Labeling · Supplement 7 · standardAP
2011-05-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →